Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Oct 2003 Drugs for the Shy? Jeremy A. Lazarus, MD Virtual Mentor. 2003;5(10):405-407. doi: 10.1001/virtualmentor.2003.5.10.ccas1-0310. Policy Forum Nov 2003 "You Can Pay Me Now, Or You Can Pay Me Later" Geoffrey C. Williams, MD, PhD Virtual Mentor. 2003;5(11):518-522. doi: 10.1001/virtualmentor.2003.5.11.pfor2-0311. In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003;194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307. State of the Art and Science Jun 2003 Reducing the Effects of Low Health Literacy Faith Lagay, PhD Virtual Mentor. 2003;5(6):222-224. doi: 10.1001/virtualmentor.2003.5.6.cprl1-0306. Health Law Jul 2003 Is it Legal for a Physician to Receive Payment for Prescribing a Drug? Kristin A. Sorenson Virtual Mentor. 2003;5(7):260-262. doi: 10.1001/virtualmentor.2003.5.7.hlaw1-0307. Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725. Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783. Case and Commentary Sep 2001 Obligations to Noncompliant Patients Faith Lagay, PhD Virtual Mentor. 2001;3(9):289-290. doi: 10.1001/virtualmentor.2001.3.9.hlaw1-0109. State of the Art and Science Jun 2001 Genetic Disparity: Unfair or Only Unfortunate? Faith Lagay, PhD Virtual Mentor. 2001;3(6):187-190. doi: 10.1001/virtualmentor.2001.3.6.gnth1-0106. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Oct 2003 Drugs for the Shy? Jeremy A. Lazarus, MD Virtual Mentor. 2003;5(10):405-407. doi: 10.1001/virtualmentor.2003.5.10.ccas1-0310.
Policy Forum Nov 2003 "You Can Pay Me Now, Or You Can Pay Me Later" Geoffrey C. Williams, MD, PhD Virtual Mentor. 2003;5(11):518-522. doi: 10.1001/virtualmentor.2003.5.11.pfor2-0311.
In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003;194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307.
State of the Art and Science Jun 2003 Reducing the Effects of Low Health Literacy Faith Lagay, PhD Virtual Mentor. 2003;5(6):222-224. doi: 10.1001/virtualmentor.2003.5.6.cprl1-0306.
Health Law Jul 2003 Is it Legal for a Physician to Receive Payment for Prescribing a Drug? Kristin A. Sorenson Virtual Mentor. 2003;5(7):260-262. doi: 10.1001/virtualmentor.2003.5.7.hlaw1-0307.
Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725.
Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783.
Case and Commentary Sep 2001 Obligations to Noncompliant Patients Faith Lagay, PhD Virtual Mentor. 2001;3(9):289-290. doi: 10.1001/virtualmentor.2001.3.9.hlaw1-0109.
State of the Art and Science Jun 2001 Genetic Disparity: Unfair or Only Unfortunate? Faith Lagay, PhD Virtual Mentor. 2001;3(6):187-190. doi: 10.1001/virtualmentor.2001.3.6.gnth1-0106.